Jared Techau
About Jared Techau
Jared Techau serves as the Global TIL Clinical Logistics Manager at Instil Bio, where he has worked since 2020. With a background in eye, tissue, and organ donation, he transitioned to gene and cell therapy and has extensive experience in the biopharmaceutical industry.
Work at Instil Bio
Jared Techau has been serving as the Global TIL Clinical Logistics Manager at Instil Bio since 2020. In this role, he oversees the logistics associated with tumor-infiltrating lymphocyte (TIL) therapy, contributing to the company's efforts in advancing cell therapy treatments. His experience in clinical logistics is pivotal to ensuring efficient operations within the biopharmaceutical sector.
Education and Expertise
Jared Techau holds a Bachelor of Science in Biology from the University of Kentucky, where he studied from 2007 to 2011. He furthered his education by obtaining a Master of Biomedical Sciences from Midwestern University in Arizona between 2011 and 2013. He also completed a Post-Baccalaureate program in Pre-Medicine/Pre-Medical Studies at the University of California, Los Angeles from 2017 to 2019. His academic background supports his expertise in the biopharmaceutical industry, particularly in clinical logistics for CAR-T therapy.
Background in Clinical Logistics
Before joining Instil Bio, Jared Techau gained significant experience in the biopharmaceutical industry. He worked at Kite Pharma as a Clinical Logistics Coordinator from 2018 to 2020 and as a Senior Specialist for seven months in 2020. His earlier roles included serving as a Surgical Recovery Coordinator at OneLegacy from 2014 to 2018 and as an Ocular Recovery Technician at Donor Network of Arizona from 2013 to 2014. This diverse background has equipped him with a comprehensive understanding of clinical logistics.
Research Experience
During his graduate studies, Jared Techau conducted research focused on the neuroprotective effects of nicotine in Parkinson’s disease. This research experience adds to his scientific knowledge and informs his work in the biopharmaceutical field, particularly in understanding the complexities of therapeutic interventions.